-
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
29 Mar 2024 01:58 GMT
… in place due to prior vaccinations against the ancestral strain. … like from the initial SARS-CoV-2 vaccines, to shape immune … years later.
“Detailing how SARS-CoV-2 immune history … produce neutralizing antibodies against new SARS-CoV-2 variants,” Hensley …
-
High Resolution Immune Profiling Assay Characterizes the Antibody Response to Moderna’s COVID-19 Vaccine
28 Mar 2024 20:31 GMT
… profiles to SARS-CoV-2 messenger RNA (mRNA) based vaccines. This study … primary and variant-updated booster vaccinations. Notably, epitope identify changed after … the development of multiplex diagnostics, vaccines and therapeutics. The company was …
-
Vaccines in Development
28 Mar 2024 17:53 GMT
… RNA vaccine. Another competitive market is vaccines for … Brazil has an admirable vaccination program and internationally recognized … training of excellent immunologists, vaccinologists, and infectious disease … SpiN-Tec, a vaccine against SARS-CoV-2, now …
-
Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection
28 Mar 2024 13:58 GMT
… of a novel SARS-coronavirus-2 (SARS-CoV-2) and … the development of effective vaccines for SARS-CoV-2 has … population that are not fully vaccinated. Furthermore, there remains … and biocompatibility.
While conventional vaccines have been extensively studied …
-
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
28 Mar 2024 13:00 GMT
… company developing immunotherapies and vaccines against cancers and infectious … , DC
Presentation Title: Vaccine Induction of Broadly-Specific … (N) antigens of SARS-CoV-2 and is specifically … oncology products and preventative vaccines will receive regulatory …
-
Do you need a spring COVID-19 vaccine? Research backs extra round for high-risk groups
28 Mar 2024 09:16 GMT
… does note that getting vaccinated during pregnancy can protect … against serious outcomes.
"Vaccinated people can also pass … for pragmatic reasons, [COVID vaccinations] will dovetail with seasonal flu … patients who tested positive for SARS-CoV-2, the virus …
-
Moderna’s Next-Gen COVID-19 Vaccine Outperforms Spikevax in Phase 3 Trial
27 Mar 2024 22:27 GMT
… original virus strains of SARS-CoV-2 compared with … the mRNA-1273.222 vaccine.
The vaccine also had comparable safety … potentially expanding access to the vaccine, and promoting better public … of immunizations.
Unlike traditional vaccines that use weakened or …
-
#GotGlycans: Role of N343 Glycosylation on the SARS-CoV-2 S RBD Structure and Co-Receptor Binding Across Variants of Concern
27 Mar 2024 17:14 GMT
… protein scaffold for COVID-19 vaccines(Dickey et al., 2022; … design of novel COVID-19 vaccines that may or may not … vaccine design. Indeed, earlier work shows SARS-CoV-2 S-based protein vaccines … 2022), and of RBD-based vaccines in use and under development …
-
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints
27 Mar 2024 10:55 GMT
… reactogenicity, immunogenicity, and relative vaccine efficacy (rVE) of the … immune response against the SARS-CoV-2 virus, including … healthcare providers and improve vaccine access in public … our fourth infectious disease vaccine programme with positive Phase …
-
COVID vaccines cut heart failure and blood clot risks by up to 78%
27 Mar 2024 10:21 GMT
… other thromboembolic events following vaccination, this analysis highlights … it comes from the SARS-CoV-2 infection itself … protective effects of COVID vaccines against severe health complications … the importance of widespread vaccination efforts in protecting …